Professional
Added to YB: 2025-03-03
Pitch date: 2024-12-31
LEGN [bullish]
Legend Biotech Corporation
+6.58%
current return
Author Info
No bio for this author
Company Info
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally.
Market Cap
$6.7B
Pitch Price
$32.85
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
growth
Meridian Contrarian Fund Added On Portfolio Holding: Legend Biotech Corporation
LEGN added: Developing promising CAR-T cancer drug with J&J. Stock pressured by ex-CEO controversy & China concerns. Competitor fears impacting sales, but our research sees inferior rival. Well-positioned, added on weakness. Biotech team confident in drug potential & J&J partnership.
Read full article (1 min)